Julianne Bruno Crispr Therapeutics Ag (CRSP) insider trading activity

Julianne Bruno is Chief Operating Officer of CRISPR Therapeutics AG. Currently has a direct ownership of 8,508 shares of CRSP, which is worth approximately $350,699. The most recent transaction as insider was on Mar 12, 2025, when has been sold 190 shares (Common Shares) at a price of $43.32 per share, resulting in proceeds of $8,230. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 8.51K

26.14% 3M change

n/a 12M change

Total Value Held $350,699

Julianne Bruno Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 12 2025	SELL Open market or private sale	$8,230 $43.32 p/Share	190 Reduced 2.18%	8,508 Common Shares
Mar 11 2025	SELL Open market or private sale	$50,819 $42.42 p/Share	1,198 Reduced 12.66%	8,263 Common Shares
Mar 11 2025	BUY Exercise of conversion of derivative security	-	435 Added 4.76%	8,698 Common Shares
Mar 10 2025	BUY Exercise of conversion of derivative security	-	2,399 Added 20.23%	9,461 Common Shares
Feb 19 2025	SELL Open market or private sale	$17,582 $52.8 p/Share	333 Reduced 4.5%	7,062 Common Shares
Feb 18 2025	BUY Exercise of conversion of derivative security	-	650 Added 8.08%	7,395 Common Shares
Jun 21 2024	SELL Open market or private sale	$188,798 $56.09 p/Share	3,366 Reduced 33.29%	6,745 Common Shares
Jun 20 2024	BUY Exercise of conversion of derivative security	-	7,000 Added 40.91%	10,111 Common Shares

Julianne Bruno

Chief Operating Officer

Boston, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRSP shares.

Notify only if

Value

Insider Trading

Get notified when an Crispr Therapeutics Ag insider buys or sells CRSP shares.

Notify only if

Operation

Value

Type

News

Receive news related to CRISPR Therapeutics AG

Track Activities on CRSP

Account